Wither New Biotech Startups?

Biotech venture capital funding remains robust, but a troubling trendline in venture formation suggests a change in new startup activity

Source: Forbes.com Healthcare News - January 27, 2020 Category: Pharmaceuticals Authors: Bruce Booth, Contributor Source Type: news